Ticker
MRKRCompany Name
MARKER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -14.56M | -270.18% | $ 5.39M |
3/31/2025 | $ -12.73M | -223.57% | $ 5.7M |
12/31/2024 | $ -10.68M | -162.06% | $ 6.59M |
9/30/2024 | $ -9.69M | -179.64% | $ 5.4M |
6/30/2024 | $ -10.37M | -278.12% | $ 3.73M |
3/31/2024 | $ -5.66M | -170.39% | $ 3.32M |
12/31/2023 | $ -8.23M | -248.65% | $ 3.31M |
9/30/2023 | $ -9.29M | -102.5% | $ 9.06M |
6/30/2023 | $ -13.23M | -103.7% | $ 12.76M |
3/31/2023 | $ -24.99M | -195.47% | $ 12.78M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for MARKER THERAPEUTICS INC is calculated as follows: EBIT [ $ -25.28M ] / Revenues [ $ 679.98K ]
(=) EBIT % [ -3717.47% ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |